— Know what they know.
Not Investment Advice

LNSR NASDAQ

LENSAR, Inc.
1W: +2.1% 1M: +9.4% 3M: -49.1% YTD: -48.8% 1Y: -57.4% 3Y: +157.6% 5Y: -25.5%
$6.09
+0.14 (+2.35%)
 
Weekly Expected Move ±8.4%
$5 $5 $6 $6 $6
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Buy · Power 60 · $73.7M mcap · 9M float · 1.37% daily turnover · Short 58% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$58M +9.2% ▲
5Y CAGR: +17.2%
Gross Profit
$27M +4.9% ▲
5Y CAGR: +14.0%
Operating Income
-$24M -121.8% ▼
Net Income
-$34M -9.2% ▼
EPS (Diluted)
$-2.87 -5.1% ▼
EBITDA
-$24M -687.3% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$34M$35M$42M$53M$58M
YoY Growth+30.6%+2.6%+19.2%+26.9%+9.2%
Cost of Revenue$17M$15M$21M$28M$31M
Gross Profit$18M$20M$21M$26M$27M
Gross Margin51.8%56.4%50.1%48.3%46.4%
R&D Expenses$12M$12M$6M$5M$6M
SG&A Expenses$24M$27M$26M$26M$45M
Operating Expenses$37M$40M$33M$37M$51M
Operating Income-$20M-$20M-$12M-$11M-$24M
Operating Margin-57.0%-57.1%-29.0%-19.9%-40.5%
Interest Expense$0$0$0$0$0
Income Before Tax-$20M-$20M-$14M-$31M-$34M
Tax Expense$0$0$0$0$0
Net Income-$20M-$20M-$14M-$31M-$34M
Net Margin-56.9%-56.3%-34.1%-58.7%-58.7%
EPS (Diluted)$-2.10$-1.96$-1.31$-2.73$-2.87
EBITDA-$17M-$17M-$9M-$3M-$24M
Shares Outstanding9M10M11M12M12M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms